LLY240816P925000
- 39.30
- +4.97+14.48%
Eli Lilly and Co Newsroom
Jim Cramer Considers Eli Lilly and Company (LLY) a 'Best of Breed' Stock
Eli Lilly +5%, Named 'Top Pick' Following Q2 Beat Morgan Stanley Says
Eli Lilly To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Express News | Market-Moving News for August 12th
Express News | Eli Lilly Files for Five Part, Notes Offering; Size Not Disclosed - SEC Filing
Express News | Eli Lilly Shares Are Trading Higher After Deutsche Bank Upgraded the Stock From Hold to Buy and Raised Its Price Target From $725 to $1,025
Big Tech, Health-Care and High-Yield Stocks Are Dip-Buying Targets
Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock
Eli Lilly Analyst Ratings
Stock Market Movers: KeyCorp, Monday.com, Starbucks, Barrick Gold, and More
Express News | Eli Lilly and Company : Deutsche Bank Raises to Buy From Hold
Express News | Eli Lilly and Company : Deutsche Bank Raises Target Price to $1025 From $725
Bank of America raises Eli Lilly and Co's target price to $1125.
Bank of America: Raised the target price of Eli Lilly and Co from $1000 to $1125, maintaining a "buy" rating.
Barclays Remains a Buy on Eli Lilly & Co (LLY)
What Eli Lilly, Novo Nordisk Earnings Reveal About the Future of GLP-1 Sales
About 73% of the S&P 500 Names Beat on EPS During the Week - Earnings Scorecard
Why Are Hedge Funds Bullish on Eli Lilly and Company (LLY) Now?
Eli Lilly and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
12 Out of 17 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard